Brian Wells(@bwells80) 's Twitter Profile Photo

Elliot K Fishman / CTisus.com: RT Lustgarten Foundation: πŸ™Œ Exciting news from
American Cancer Society's Cancer Facts & Figures 2023: the 5-year survival rate for increases 1%, reaching an all-time high of 12% πŸ’œ While we celebrate this progress…

#RT @ctisus: RT @lustgartenfdn: #ProgressIsParamount πŸ™Œ Exciting news from 
@AmericanCancer's Cancer Facts & Figures 2023: the 5-year survival rate for #pancreaticcancer increases 1%, reaching an all-time high of 12% πŸ’œ While we celebrate this progress…
account_circle
Lustgarten Foundation(@lustgartenfdn) 's Twitter Profile Photo

LUSTGARTEN-FUNDED RESEARCH: Scientists have developed a blood test that can accurately detect early-stage pancreatic cancer, according to results from a large study. lfdn.org/4bzGK4D

City of Hope Swim Across America AACR

LUSTGARTEN-FUNDED RESEARCH: Scientists have developed a blood test that can accurately detect early-stage pancreatic cancer, according to results from a large study. lfdn.org/4bzGK4D
#ResearchIsFundamental #ProgressIsParamount
@cityofhope @SAAswim @AACR
account_circle
Lustgarten Foundation(@lustgartenfdn) 's Twitter Profile Photo

We are resolved to turn hope into breakthroughs in 2024! ✨ Thanks to your continued support, we are transforming into a curable disease. πŸ’œ

Let's hear it, Lustgarten community β€” drop your New Year's resolutions below! πŸ‘‡

We are resolved to turn hope into breakthroughs in 2024! ✨ Thanks to your continued support, we are transforming #pancreaticcancer into a curable disease. πŸ’œ

Let's hear it, Lustgarten community β€” drop your New Year's resolutions below! πŸ‘‡

#ProgressIsParamount #CommunityIsPower
account_circle
Lustgarten Foundation(@lustgartenfdn) 's Twitter Profile Photo

According to 3-year follow up results reported at the AACR Annual Meeting 2024, immune response to autogene cevumeran, an investigational individualized neoantigen-specific mRNA vaccine, correlates with clinical benefit. πŸ’‰ Read: lfdn.org/49saWgz

According to 3-year follow up results reported at the @AACR Annual Meeting 2024, immune response to autogene cevumeran, an investigational individualized neoantigen-specific mRNA vaccine, correlates with clinical benefit. πŸ’‰ Read: lfdn.org/49saWgz
#ProgressIsParamount
account_circle
Lustgarten Foundation(@lustgartenfdn) 's Twitter Profile Photo

Just in! πŸ’œ For the first time in a decade, a potential new standard-of-care first-line therapy in metastatic pancreatic adenocarcinoma was approved by the FDA! READ MORE: lfdn.org/49xuwse
IpsenUS

Just in! πŸ’œ For the first time in a decade, a potential new standard-of-care first-line therapy in metastatic pancreatic adenocarcinoma was approved by the FDA! READ MORE: lfdn.org/49xuwse 
@IpsenUS #ResearchIsFundamental #ProgressIsParamount
account_circle
Lustgarten Foundation(@lustgartenfdn) 's Twitter Profile Photo

What an incredible day! Huge thanks to Lance Kawaguchi for inviting us to join the closing bell ceremony at @NASDAQ. It was such an honor to share this unforgettable experience with so many wonderful organizations, including our new partners at @CRI! πŸ’œ

What an incredible day! Huge thanks to @LanceKawaguchi for inviting us to join the closing bell ceremony at @NASDAQ. It was such an honor to share this unforgettable experience with so many wonderful organizations, including our new partners at @CRI! πŸ’œ #ProgressIsParamount
account_circle
Lustgarten Foundation(@lustgartenfdn) 's Twitter Profile Photo

In just 2️⃣ weeks, in celebration of , we will host The Power of Persistenceβ€”Women Transforming Cancer Research and Care with the Salk Institute! Register today at lfdn.org/49FdBUS

In just 2️⃣ weeks, in celebration of #InternationalWomensDay, we will host The Power of Persistenceβ€”Women Transforming Cancer Research and Care with the @salkinstitute! Register today at lfdn.org/49FdBUS
#ProgressIsParamount #pancreaticcancer
account_circle
Lustgarten Foundation(@lustgartenfdn) 's Twitter Profile Photo

! πŸ™Œ American Cancer Society dropped their Cancer Facts & Figures 2024, reporting that the 5-year relative survival rate for is now 13%! πŸ’œ Together, we are inspiring hope & transforming PC into a curable disease. READ MORE: lfdn.org/3U4c7P5

#ProgressIsParamount! πŸ™Œ @AmericanCancer dropped their Cancer Facts & Figures 2024, reporting that the 5-year relative survival rate for #pancreaticcancer is now 13%! πŸ’œ Together, we are inspiring hope & transforming PC into a curable disease. READ MORE: lfdn.org/3U4c7P5
account_circle
Lustgarten Foundation(@lustgartenfdn) 's Twitter Profile Photo

Celebrate with the Lustgarten Foundation and Salk Institute as we host The Power of Persistenceβ€”Women Transforming Cancer Research and Care symposium. πŸ‘©β€πŸ”¬ Register today! πŸ’œ

lfdn.org/49FdBUS

Celebrate #InternationalWomensDay with the Lustgarten Foundation and @salkinstitute as we host The Power of Persistenceβ€”Women Transforming Cancer Research and Care symposium. πŸ‘©β€πŸ”¬ Register today! πŸ’œ
#ProgressIsParamount #pancreaticcancer
lfdn.org/49FdBUS
account_circle
Lustgarten Foundation(@lustgartenfdn) 's Twitter Profile Photo

Be a force for progress and register for the Atlanta Walk for Research today! πŸ’œ Looking for some inspiration? Check out Atlanta Walk leader Stefanie Wayco's story about how she turned grief into action: lfdn.org/3Iov6Nu

Be a force for progress and register for the Atlanta Walk for Research today! πŸ’œ Looking for some inspiration? Check out Atlanta Walk leader Stefanie Wayco's story about how she turned grief into action: lfdn.org/3Iov6Nu
#ProgressIsParamount #CommunityIsPower
account_circle
Lustgarten Foundation(@lustgartenfdn) 's Twitter Profile Photo

πŸ™Œ Exciting news from
American Cancer Society's Cancer Facts & Figures 2023: the 5-year survival rate for increases 1%, reaching an all-time high of 12% πŸ’œ While we celebrate this progress, there's still much to be done. bit.ly/3XCuwRA

#ProgressIsParamount πŸ™Œ Exciting news from 
@AmericanCancer's Cancer Facts & Figures 2023: the 5-year survival rate for #pancreaticcancer increases 1%, reaching an all-time high of 12% πŸ’œ While we celebrate this progress, there's still much to be done. bit.ly/3XCuwRA
account_circle
Lustgarten Foundation(@lustgartenfdn) 's Twitter Profile Photo

In 2018, the FDA granted Breakthrough Device Designation for CancerSEEK, a liquid biopsy for β€” Lustgarten is a longtime funder of this research. πŸ™ŒπŸ’œ Johns Hopkins Kimmel Cancer Center
READ: lfdn.org/3PffX5h

In 2018, the FDA granted Breakthrough Device Designation for CancerSEEK, a liquid biopsy for #pancreaticcancer β€” Lustgarten is a longtime funder of this research. πŸ™ŒπŸ’œ #MilestoneMonday #ProgressIsParamount #ResearchIsFundamental @hopkinskimmel 
READ: lfdn.org/3PffX5h
account_circle
Lustgarten Foundation(@lustgartenfdn) 's Twitter Profile Photo

Exciting news! πŸ”¬ After encouraging results from a phase I trial, funded by Lustgarten, a phase 2 clinical trial has now opened to test the effectiveness of using an mRNA vaccine to fight pancreatic cancer @MSKCC lfdn.org/44g13jn

account_circle
Lustgarten Foundation(@lustgartenfdn) 's Twitter Profile Photo

The 2024 ASCO Gastrointestinal Cancers Symposium revealed some promising developments in the diagnosis and treatment of ! πŸ’œ Check out the full recap of the symposium from our partner Let's Win Pancreatic Cancer πŸ’œ here: lfdn.org/3SPCSpN

account_circle
Lustgarten Foundation(@lustgartenfdn) 's Twitter Profile Photo

Last Wednesday, research pioneers, experts, & early career investigators united LIVE in NYC for , Lustgarten's inaugural research symposium, honoring our 25th anniversary year. πŸ’œ lfdn.org/3ut87gE

account_circle
Lustgarten Foundation(@lustgartenfdn) 's Twitter Profile Photo

We are thrilled to announce an EXTRAORDINARY year of research grants fueling bold and innovative research! Thank you for your continued support! Together, we are transforming pancreatic cancer into a curable disease!
lfdn.org/3OiiIRz

account_circle
Lustgarten Foundation(@lustgartenfdn) 's Twitter Profile Photo

On Tuesday, March 12, 2024, we celebrated at the prestigious Salk Institute for β€œThe Power of Persistence: Women Transforming Cancer Research & Care.” Check out a recap of this powerhouse program here: lfdn.org/3TjKyiL

account_circle
Lustgarten Foundation(@lustgartenfdn) 's Twitter Profile Photo

Lustgarten-funded scientists are leading the way! πŸ‘ Ugwuji Maduekwe, 2022 LEAD Project grantee Yeh Lab, closed out today's session with a discussion about disparities in care and mechanisms of intervention to address them.πŸ’œ

account_circle